SV2016005282A - NEW COMPOUNDS - Google Patents

NEW COMPOUNDS

Info

Publication number
SV2016005282A
SV2016005282A SV2016005282A SV2016005282A SV2016005282A SV 2016005282 A SV2016005282 A SV 2016005282A SV 2016005282 A SV2016005282 A SV 2016005282A SV 2016005282 A SV2016005282 A SV 2016005282A SV 2016005282 A SV2016005282 A SV 2016005282A
Authority
SV
El Salvador
Prior art keywords
compounds
new compounds
enbossing
pharmaceutics
inhibitors
Prior art date
Application number
SV2016005282A
Other languages
Spanish (es)
Inventor
Kai Thede
Eckhard Bender
William Scott
Anja Giese
Ludwig Zorn
Ningshu Liu
Ursula Mönning
Franziska Siegel
Philip Lienau
Daniel Basting
Dirk Schneider
Manfred Möwes
Jens Geisler
Stefan Golz
Andrea Hägebarth
Florian Puehler
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of SV2016005282A publication Critical patent/SV2016005282A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A INHIBIDORES DE LAS VÍAS DE SEÑALIZACIÓN DE WNT DE LA FÓRMULA GENERAL (I) COMO SE DESCRIBE Y SE DEFINE EN LA PRESENTE, A MÉTODOS DE PREPARACIÓN DE DICHOS COMPUESTOS, A COMPUESTOS INTERMEDIARIOS ÚTILES PARA PREPARAR DICHOS COMPUESTOS, A COMPOSICIONES FARMACÉUTICAS Y COMBINACIONES QUE COMPRENDEN DICHOS COMPUESTOS Y AL USO DE DICHOS COMPUESTOS PARA PRODUCIR UNA COMPOSICIÓN FARMACÉUTICA PARA EL TRATAMIENTO O LA PREVENCIÓN DE UNA ENFERMEDAD, EN PARTICULAR DE UN TRASTORNO HIPERPROLIFERATIVO, COMO UN ÚNICO AGENTE O EN COMBINACIÓN CON OTROS INGREDIENTES ACTIVOSTHE PRESENT INVENTION REFERS TO INHIBITORS OF THE WNT SIGNALING ROUTES OF THE GENERAL FORMULA (I) AS DESCRIBED AND DEFINED HEREIN, TO PREPARATION METHODS OF SUCH COMPOUNDS, TO INTERMEDIARY COMPOUNDS TO PREPARE THESE COMPOUNDS, PHARMACEUTICS AND COMBINATIONS THAT INCLUDE SUCH COMPOUNDS AND THE USE OF SUCH COMPOUNDS TO PRODUCE A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF A DISEASE, IN PARTICULAR OF A HYPERPROLIFERATIVE DISORDER, AS A UNIQUE ENBOSSING

SV2016005282A 2014-03-20 2016-09-20 NEW COMPOUNDS SV2016005282A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461968172P 2014-03-20 2014-03-20
EP14185274 2014-09-18

Publications (1)

Publication Number Publication Date
SV2016005282A true SV2016005282A (en) 2018-12-05

Family

ID=65628886

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2016005282A SV2016005282A (en) 2014-03-20 2016-09-20 NEW COMPOUNDS

Country Status (5)

Country Link
CL (1) CL2016002368A1 (en)
IL (1) IL247327A0 (en)
MA (1) MA39762A (en)
SV (1) SV2016005282A (en)
ZA (1) ZA201605726B (en)

Also Published As

Publication number Publication date
ZA201605726B (en) 2019-11-27
MA39762A (en) 2017-01-25
IL247327A0 (en) 2016-09-29
CL2016002368A1 (en) 2017-03-03

Similar Documents

Publication Publication Date Title
CL2017001204A1 (en) 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
NI201600144A (en) QUINOXALINE DERIVATIVES USEFUL AS MODULATORS OF FGFR KINASE
EA201691582A1 (en) NEW PHARMACEUTICAL PREPARATIONS
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
DOP2016000253A (en) NEW COMPOUNDS
CL2016002072A1 (en) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease
DOP2015000274A (en) CHEMICAL COMPOUNDS
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
CL2017001046A1 (en) Bromodomain Inhibitors
EA201691216A1 (en) COMPOUNDS OF LINACLOTIDE WITH Slow Release
EA201591728A1 (en) HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION
UY36224A (en) TRICYCLIC COMPOUNDS OF IMIDAZO-PIRIMIDINONA
EA201500801A1 (en) BENZOHINOLONE INHIBITORS VMAT2
SV2017005412A (en) COMPOUNDS OF 1-RENT-6-OXO-1,6-DIHIDROPIRIDIN-3-ILO AND USES OF THE SAME
BR112016021034A2 (en) PHARMACEUTICAL COMPOSITION, USE OF SUCH COMPOSITION, METHOD TO TREAT A DISEASE AND KIT
ECSP16074478A (en) NOVEL COMPOUNDS
ECSP16008797A (en) DERIVATIVES OF HETEROBICICLOARIL AS RORC2 INHIBITORS AND METHODS OF USE OF THE SAME
GT201500247A (en) IMIDAZOPIRIDAZINAS REPLACED
DOP2016000212A (en) CONDENSED HETEROCICLES REPLACED AS MODULATORS OF GPR119 FOR THE TREATMENT OF DIABETES, OBESITY, DISLIPIDEMIA AND RELATED DISORDERS
CL2016000038A1 (en) Pyroxolo-substituted pyridinamines
DOP2016000297A (en) PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT INFECTIOUS DISEASES
EA201690783A1 (en) SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES
CR20160133A (en) SUBSTITUTED PHENYLALANINE DERIVATIVES
SV2016005293A (en) AMIDO-REPLACED AZOL COMPOUNDS AS INHIBITORS OF TNKS1 AND / OR TNKS2